ELITE PHARMACEUTICALS INC /NV/ (ELTP) › Gross ProfitELITE PHARMACEUTICALS INC /NV/ (ELTP) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2011: $1.59M2012: $1.41M2013: $1.09M2014: $1.37M2015: $2.00M2016: $8.01M2017: $3.74M2018: $3.95M2019: $2.87M2020: $7.98M2021: $11.87M2022: $14.80M2023: $16.59M2024: $26.36M2025: $40.09M$40.09M2011Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$40.09M+52.1%2024$26.36M+58.8%2023$16.59M+12.2%2022$14.80M+24.7%2021$11.87M+48.7%2020$7.98M+178.2%2019$2.87M-27.4%2018$3.95M+5.6%2017$3.74M-53.3%2016$8.01M+300.4%2015$2.00M+46.6%2014$1.37M+25.4%2013$1.09M-22.8%2012$1.41M-11.3%2011$1.59M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share